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OBJECTIVES We evaluated the coronary vasodilatory effects of transcutaneous low-frequency (27-kHz)
ultrasound (USD).
BACKGROUND Ultrasound has been shown to affect vascular function.
METHODS Ultrasound energy was administered transcutaneously to 12 dogs. Coronary arterial dimen-
sions were assessed using intravascular coronary ultrasound (IVUS) and quantitative coronary
angiography (QCA).
RESULTS The IVUS mid-left anterior descending (LAD) luminal area was 6.77  1.27 mm2 at
baseline. After 30 s of ultrasound, this area increased by 9% (7.40  1.44 mm2, p  0.05),
after 3 min by 19% (8.05  1.72 mm2, p  0.05) and after 5 min increased by 21% (8.16 
1.29 mm2, p  0.05). The mean coronary diameter (2.69  0.33 mm) at baseline (QCA of
three segments of LAD and three segments of left circumflex coronary artery) increased by
19.3% (3.21  0.28 mm) after 5 min of USD exposure. After a 90-min observation period
there was a return to baseline values (p  NS). Intracoronary nitroglycerin (NTG)
administered to five dogs revealed a similar magnitude of vasodilation as USD.
CONCLUSIONS Noninvasive, transthoracic low-frequency USD energy results in coronary artery vasodilation
within seconds of exposure. The vasodilation is reversible and is similar in magnitude to that
induced by NTG. Further evaluation is needed to assess its potential applications in
humans. (J Am Coll Cardiol 2003;41:1623–7i) © 2003 by the American College of
Cardiology Foundation
Invasive, catheter-delivered, low-frequency (20 kHz) high-
intensity ultrasound (USD) has been shown to cause vaso-
dilation in peripheral and coronary arteries in animals and in
humans (1–3). However, there are no data on the vasomotor
effects of transcutaneous USD. In this study, we evaluated
the potential vasodilatory effects of transcutaneous low-
frequency USD in canine coronary arteries, as such a
noninvasive approach could represent a novel method for
treatment of coronary syndromes.
See page 1628
METHODS
Twelve dogs (20 to 30 kg) were anesthetized with thiopental
and maintained by isoflurane inhalation. The dogs received
heparin 1,000 U subcutaneously. Studies were performed
according to the position of the American Heart Associa-
tion on research animal use.
Transcutaneous USD device. The device consists of a
generator/amplifier and controller delivering 27-kHz
pulsed-wave USD through a transducer placed over the
mid-sternum of the thorax (Timi3 Systems, Inc., Santa
Clara, California). The transducer-radiating surface faces
the skin and it is coupled to the skin with USD gel.
Ultrasound intensity is approximately 1.4 W/cm2 and the
pulsed wave duty is cycle 30%. The beam shape of the USD
field is diverging and covers the entire heart. Because of the
diverging USD field, the acoustic pressure further away
from the transducer face is lower than at 5 mm from the
transducer. At 5 mm, the peak rarefactional (i.e., negative)
pressure is 230 kPa, at 4 cm about 170 kPa, and at 10 cm
about 100 kPa. In short, between 4 and 10 cm from the
transducer face the peak rarefactional pressure decreases
from about 170 kPa to about 100 kPa. The output of the
transducer was measured with a calibrated hydrophone
(model 8103 Bru¨el & Kæjr, Nærum, Denmark) in accor-
dance with the existing guidelines and standards (4–6).
Intravascular coronary ultrasound (IVUS). As shown in
Figure 1, after coronary angiography for baseline measure-
ments, IVUS was performed in the mid-left anterior de-
scending coronary artery (LAD) in 11 of 12 dogs. Luminal
areas were continuously monitored during 5 min of USD
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exposure using a CVIS imaging system and coronary cath-
eters (3 F, 40 MHz Atlantis SR and 3.2 F, 30 MHz,
Ultracross, Boston Scientific, Massachusetts) (Fig. 2). In
five dogs, intracoronary nitroglycerin (NTG) (100 g) was
administered 90 min after stopping USD. The IVUS
recordings were analyzed by an independent core laboratory
(7) blinded to the status of the dog, whether control period
or during the NTG or USD exposure phase of the study
(Cardiovascular Core Analysis Laboratory, Stanford Uni-
versity, Stanford, California).
Coronary angiography protocol. As noted in Figure 1,
coronary angiograms were performed at baseline in the
anterior-posterior and selected oblique projections after 5,
30, 60, and 90 min of USD, as well as 30, 60, and 90 min
after stopping USD. In five dogs after the 90-min observa-
tion period, quantitative coronary angiography (QCA) was
also performed 5 min after intracoronary NTG administra-
tion. Six segments (three LAD and three left circumflex
[LCx]) were serially measured by QCA (Fig. 2). Arterial
diameters were measured using a computer edge detection
program (Advantx DXC Digital System, General Electric
Medical Systems, Milwaukee, Wisconsin).
Safety testing. During transcutaneous USD exposure, skin
temperature below the transducer was measured by a ther-
mocouple sensor (MedSource Inc., Santa Clara, California).
Blood temperature within the LAD was measured with a
thermocouple sensor (Timi3 Systems Inc.) mounted on a
coronary guidewire placed in the mid-portion of the LAD.
Pathologic studies. Dogs were euthanized; hearts were
excised and fixed in formalin for 24 to 72 h and then cut
transversely in 1-cm intervals from apex to base. Represen-
tative sections from the LAD and LCx arteries, as well as
the skin, soft tissues, myocardium, and lung were submitted
for microscopic examination.
Statistical analysis. Continuous variables are expressed as
mean standard deviation or percent change. Intraobserver
and interobserver agreements were assessed using regression
analysis and the Bland-Altman method. To assess changes
from baseline to various time points, repeated measures anal-
ysis of variance was employed. Post hoc comparisons of all time
points with baseline were performed using Dunnett’s proce-
dure, which controls the experiment-wise type I error rate. A
value of p  0.05 was considered statistically significant.
RESULTS
IVUS measurements. Figure 3 demonstrates mean mid-
LAD luminal area at baseline, after 30 s, and each minute
Abbreviations and Acronyms
IVUS  intravascular coronary ultrasound
LAD  left anterior descending coronary artery
LCx  left circumflex coronary artery
NTG  nitroglycerin
QCA  quantitative coronary angiography
USD  ultrasound
Figure 1. The protocol and timing of coronary angiography, intravascular coronary ultrasound (IVUS), ultrasound (USD) exposure as well as nitroglycerin
(NTG) administration. OB  observation.
Figure 2. Canine coronary artery segments. The canine left coronary
angiogram was divided into six segments: three left anterior descending
coronary artery (LAD) and three left circumflex coronary artery (LCx)
segments. These segments were measured by quantitative coronary angiog-
raphy. The intravascular coronary ultrasound (IVUS) was recorded as
shown in the mid-LAD.
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from 1 to 5 min as well as mean percent increase area after
USD exposure. As shown, after 30 s of USD exposure,
mean luminal area increased by 9% (from 6.77  1.27 mm2
to 7.40  1.44 mm2, p  0.05), after 3 min by 19% (from
6.77  1.27 mm2 to 8.05  1.72 mm2, p  0.05), and after
5 min by 21% (from 6.77 1.27 mm2 to 8.16 1.29 mm2,
p  0.05). Dunnett’s procedure indicated that the luminal
areas after exposure to USD at all time points (30 s, 1 min,
2 min, 3 min, 4 min, 5 min) were significantly greater than
baseline luminal area.
Figure 3. The intravascular coronary ultrasound (IVUS) mid-left anterior descending coronary artery (LAD) area before and after ultrasound. On the
vertical axis is the mid-LAD IVUS area; on the horizontal axis is the time (s/min) of ultrasound exposure. Vasodilation increased incrementally with the
duration of ultrasound. (Inset upper left) Baseline IVUS image; (inset bottom right) IVUS image of vasodilation seen after 5 min of ultrasound exposure.
The IVUS mid-LAD areas in mm2  standard deviation (SD) are shown below each of the six time intervals at which the areas were measured.
Figure 4. Quantitative coronary angiography (QCA) measurements. The mean percent change of left anterior descending coronary artery (LAD) and left
circumflex coronary artery (LCx) diameter at baseline and after ultrasound (USD) exposure are shown. The vertical axis indicates the mean diameter of
the coronary artery by QCA analysis; horizontal axis shows the baseline and the eight subsequent times of measurement during and after USD exposure.
Percent change in angiographic diameter is plotted, and the average diameter in mm with standard deviation (SD) is shown below each of the nine time
intervals. 1: Baseline 1 (before USD exposure). 2: After 5 min of USD exposure. 3: Baseline 2 (after 5 min of USD exposure followed by a 60-min
observation [OB] period). 4: After 30 min of USD exposure. 5: After 60 min of USD exposure. 6: After 90 min of USD exposure. 7: After 30 min of OB.
8: After 60 min of OB. 9: After 90 min of OB. The table below the figure indicates the coronary artery diameter for each of the nine time intervals plotted
on the graph.
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QCA measurements. Figure 4 shows the data on QCA
mean luminal diameter of the LAD and LCx. There was a
19.3% mean increase in all segments from 2.69  0.33 mm
to 3.21  0.28 mm (p  0.05) after 5 min of USD. After
a 60-min observation period, mean diameter resolved to
5.6% above baseline values (p  NS). After the 60-min
observation period, USD treatment was initiated again for
90 min and angiograms as shown in Figure 5 were per-
formed at 30-, 60-, and 90-min intervals during USD
exposure. The mean increase in QCA coronary arterial
diameters was 12.6% (from 2.69  0.33 mm to 3.03  0.30
mm, p  0.05) at 30 min, 12.3 % (to 3.02  0.28 mm, p 
0.05) at 60 min, and 8.2% (to 2.91  0.28 mm, p  NS) at
90 min. During a subsequent 90-min observation period (no
USD), angiographic evaluation of luminal diameter in each
of the segments studied was repeated every 30 min. There
was a decrease in the coronary artery luminal diameter
towards baseline during the observation period after USD
exposure.
Both QCA and IVUS regression analyses indicated
strong intraobserver and interobserver correlations (r 
0.98). The Bland-Altman method indicated good agree-
ment. The averaged limits of agreement (mean difference)
for IVUS were 0.24 (0.01) mm2 and 0.58 (0.10) mm2, and
for QCA it was 0.14 (0.02) mm and 0.27 (0.11) mm. The
mean absolute percentage difference (SD) ranged from 1.0%
(1.0%) for IVUS to 4.2% (3.6%) for QCA.
NTG effect. Baseline mean luminal area measured by
IVUS in the mid-LAD was 6.95 1.40 mm2. After 100 g
intracoronary NTG, maximal luminal area increase within 5
min was 21% (8.40  1.21 mm2) over baseline. Mean
luminal QCA diameter of the LAD and LCx 5 min after
NTG administration increased 16.6% from baseline luminal
diameter (from 2.47  0.39 mm to 2.88  0.45 mm, p 
0.05). Dunnett’s procedure indicated that the luminal areas
at 1 min and 2 min were significantly greater than the
luminal area at baseline.
Temperature measurements. Skin temperature below the
transducer in four dogs was 34.9  1.08°C at baseline and
34.8  1.92°C (p  0.85) after 90 min of USD. Intracoro-
nary temperature in one dog showed no change during USD
exposure (37.0°C at baseline and 36.9°C after 60 min).
Pathologic studies. No USD-mediated injury to the cor-
onary arteries, skin, soft tissue, myocardium, or lung was
detected. Specifically, there was no thermal injury, necrosis,
or inflammatory changes in the tissues.
DISCUSSION
This is the first study to demonstrate that noninvasive,
transcutaneous low-frequency USD causes coronary artery
vasodilation. Both IVUS and QCA were used to document
that transcutaneous USD exposure results in coronary artery
vasodilation in a canine model.
Effect of short duration USD exposure. In this closed-
chest canine model, noninvasive USD exposure caused
significant vasodilation of the coronary arteries. As mea-
sured by IVUS, the vasodilation effect was apparent within
30 s of USD exposure. As shown in Figure 3, luminal area
gradually increased, resulting in a 21% increase after 5 min.
By QCA, the coronary arterial diameter also increased by
19.3% after 5 min of USD. Sixty minutes after stopping
USD, there was resolution of vasodilation, indicating that
this is a reversible phenomenon.
Effect of prolonged duration USD exposure. In the
second part of the study, the effect of the duration of USD
exposure was evaluated. After 30 and 60 min of USD
exposure, there was an increase in the mean luminal
diameter by QCA but it was less prominent than the
increase after the first short exposure of 5 min. Subsequent
arterial size reduction towards normal at 90 min despite
Figure 5. Coronary angiogram before (a) and after (b) ultrasound (USD). As shown in (b), after USD the coronary artery luminal diameter increases.
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continuation of USD exposure indicates that vasodilation
becomes attenuated over time. The QCA luminal diameter
significantly increased in response to ultrasound in all the
LAD and LCx segments studied.
Thermal analysis. Tissue heating can cause vasodilation
(8). High-intensity USD can heat tissue (9,10). Although
USD-induced vasodilation could be mediated by heating,
we found no evidence of USD tissue heating even after 90
min of USD exposure. Thus, vasodilation was not thermally
mediated in this study.
Relative vasodilatory effects of USD and NTG. The
magnitude of coronary artery vasodilation induced by USD
exposure and NTG was similar. There was a 21% increase in
luminal area by IVUS for both USD and NTG and a 19.3%
and 16.6% increase, respectively, in QCA diameter. Similar
mechanisms could be responsible for USD- and NTG-
induced vasodilation.
Mechanism of USD-induced vasodilation. We believe
that the coronary artery vasodilation is most likely a direct
effect of USD on coronary vasomotor tone. Previously
studies from our laboratory demonstrated that catheter-
delivered, low-frequency USD (20-kHz) induced vasodila-
tion in rabbit aortas (2), canine coronary arteries (1), and
human peripheral arteries (1,3). The magnitude of increase
in arterial diameter using intravascular versus external USD
was comparable, i.e., a 21% increase in canine coronary
artery diameter with intravascular delivery at 20 kHz (1) and
19.3% in this study using a 27-kHz, noninvasive, transcu-
taneous USD device. These comparable results are consis-
tent with a similar mechanism for transcatheter and trans-
cutaneous USD-induced vasodilation. In these studies of
catheter-delivered USD, the effect was limited to the
exposed artery. Recently, Suchkova et al. (11) demonstrated
that externally applied low-frequency USD (40 kHz) im-
proves tissue perfusion to muscle in ischemic limbs as well as
increasing capillary size in the exposed tissue. In addition,
they showed that when the animals were pretreated with the
nitric oxide synthase inhibitor N-nitro-L-arginine
methyl-ester, the USD enhancement of tissue perfusion as
well as capillary dilation was completely blocked. Thus, it
seems likely that the USD-induced capillary dilation and
enhanced tissue perfusion are due to a nitric oxide-
dependent mechanism. As USD energy may increase me-
chanical shear stress on the endothelial cells, it could
promote local release of the potent vasodilator nitrous oxide
(12). It is possible that low-frequency USD could induce an
increase in cardiac contractility and stroke volume and
secondarily an increase in coronary arterial size to account
for the vasodilation detected in our study. However, the
results of catheter-based, USD-induced vasodilation, as well
as the findings of Suchkova et al. (11) showing USD
enhancement of tissue perfusion and capillary size which
can be blocked by inhibition of nitric oxide synthase, are
consistent with transthoracic low-frequency USD inducing
coronary vasodilation by a nitric oxide-dependent mecha-
nism.
Study limitations. While we did measure coronary arterial
lumen size by IVUS and QCA, we did not measure the
effect of USD on coronary blood flow or velocity, or
myocardial oxygen consumption. Nonetheless, we believe
the findings of the current study are novel. Further studies
are required to delineate the time course of action and to
identify the mechanism responsible for the coronary vaso-
dilation effect of transcutaneously applied, low-frequency
USD.
Conclusions. Noninvasive, transthoracic, low-frequency
USD induces vasodilation in canine coronary arteries. The
onset of coronary vasodilation is relatively rapid (30 s).
The magnitude of the effect is similar to that found with
intracoronary NTG. This phenomenon of vasodilation that
is caused by externally applied USD energy might have the
potential to reduce myocardial ischemia in patients with
acute coronary syndromes.
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APPENDIX
The ultrasonic power and intensity emitted by the Timi3
Systems ultrasound (USD) transducer were measured using
a calibrated hydrophone. The USD transducer was con-
nected to the Timi3 USD console and placed against an
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acoustic window of a tank containing degassed water. The
water tank was lined with anechoic material to minimize
effects of standing waves. The USD field was mapped using
scanning techniques, and single-point hydrophone mea-
surements were made at the point of maximum intensity at
5 mm from the applicator face. The hydrophone used for
these measurements is a B&K type 8103 (Bru¨el & Kæjr,
Nærum, Denmark). The hydrophone diameter is 9.5 mm.
Its sensitivity at around 30 kHz is 212.7  0.25 dB re 1
V/Pa, and its calibration is traceable to the National
Institute of Standards and Technology. The hydrophone
was scanned under computer control using a stepper motor
XY-positioning system. The distance of the scan from the
applicator face was 5 mm, and all measurements were made
in a 25 by 25 rectangular grid across to the applicator face
with the step increment of 0.200 inch (5.08 mm). The USD
pressure was also measured as a function of distance from
the transducer face from 5 to 155 mm. The hydrophone signal
was digitized, and various acoustic parameters were calculated
according to International Electrotechnical Commission stan-
dards (5,6) (IEC Publication 60601-2-5), and the Food and
Drug Administration’s guidance document (4).
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